ISRCTN12825165已完成未知
Evaluation of iron stores In haemodialysis patients on maintenance ferrum carboxymaltose dosing
Dr. med. A. Kistler0 个研究点目标入组 39 人开始时间: 2019年2月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 39
研究概览
简要总结
2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30823916 results (added 10/03/2020)
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Chronic hemodialysis patients receiving either 100 or 200 mg FCM every 4 weeks.
- •2. Age 18 years or older
- •3. HD treatment for at least three months
- •4. Thrice-weekly hemodialysis
- •5. Stable FCM dosing schedule for the last two months or longer
- •6. Stable erythropoietin stimulating agents (ESAs) for patients receiving ESAs (defined by dose adjustments of <25% within the last two months)
- •7. Haemoglobin values between 95g/l and 125g/l within the last 12 weeks with a difference between the lowest and the highest value of <15g/l.
排除标准
- •1. Clinical evidence of significant blood loss within the last 12 weeks (e.g. gastrointestinal bleeding)
- •2. Significant inflammation (CRP >15 mg/l)
- •3. Hospital admission within the last month
- •4. Significant bacterial infection (e.g. pneumonia) within the last 12 weeks.
研究者
相似试验
终止
不适用
A cohort study of haemodialysis patients based on hepatic magnetic resonance imagingChronic kidney diseaseISRCTN80100088Quincy Association of Clinical Research and Therapeutics (non profit association, France)411
Unknown
不适用
Assessment of Iron Deposition in Major Organs of Hemodialysis PatientsIron OverloadNCT01169961Wolfson Medical Center20
招募中
4 期
INFERR - Iron Infusion in Haemodialysis Study: Effect of Intravenous Iron Polymaltose on survival and hospitalisation rates for Indigenous Patients with High Ferritin Levels on HaemodialysisKidney diseaseanaemiahigh ferritinlow transferrin saturationHaemodialysisBlood - AnaemiaRenal and Urogenital - Kidney diseaseInflammatory and Immune System - Other inflammatory or immune system disordersOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonLiver diseaseACTRN12620000705987Menzies School of Health Research576
已完成
3 期
Maintenance intravenous iron in hemodialysis patients to minimize erythropoietin doses: A double-blinded, randomized controlled trialMaintenance hemodialysis patients with no iron deficiency anemiaHemodialysisIntravenous iron sucroseErythropoietin-stimulating agentIron deficiency anemiaTCTR20190707001The Kidney Foundation of Thailand72
已完成
4 期
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)Anemia, Iron-DeficiencyHemodialysisKidney Failure, ChronicNCT00224081Watson Pharmaceuticals134